EPISODE · Oct 6, 2025 · 1H
Ep. 33: Breaking the Pill Paradigm: A Biopharma Insider’s Take on Chronic Disease and the FDA
from Diagnosis Redefined · host Erica Anderson
In this episode of the Diagnosis Redefined podcast, host Erica Anderson engages in a deep conversation with Dr. Urban Kiernan about the complexities of navigating health and wellness, particularly in the context of pharmaceuticals and therapeutics. They discuss the importance of personal responsibility in health decisions, the differences between traditional pharmaceuticals and newer therapeutic options, and the role of the FDA in drug approval. Dr. Kiernan shares his personal journey and insights from his extensive experience in the biopharmaceutical industry, emphasizing the need for patients to be informed and proactive in their health care choices. The conversation also touches on the intersection of politics and health, the challenges of polypharmacy, and the importance of defining success in health outcomes.TakeawaysNavigating health requires understanding both pharmaceuticals and lifestyle choices.Personal responsibility is crucial in managing health and wellness.Therapeutics differ from traditional pharmaceuticals in their application and regulation.Patients should ask their doctors about the goals and end game of prescribed medications.Informed consent is essential for understanding drug risks and benefits.The FDA approval process is complex and not always indicative of long-term safety.Polypharmacy can lead to serious health risks and should be managed carefully.The pharmaceutical industry is evolving, but challenges remain.Political changes can impact health care and pharmaceutical innovation.Empowering individuals to take charge of their health is vital for better outcomes.Chapters00:00 Navigating the Pharmaceutical Spectrum04:30 The Personal Journey of Dr. Urban Kiernan17:20 Understanding Therapeutics vs. Pharmaceuticals20:02 Empowering Patients: Questions to Ask29:46 The FDA Approval Process and Its Implications33:33 Understanding Drug Risks and Informed Consent35:32 Orphan Indications and Drug Development36:41 Navigating Side Effects and Patient Communication40:00 The Future of the Pharmaceutical Industry41:47 Research Funding and Long-Term Safety Concerns45:35 The Role of Academia vs. Industry in Research48:33 Health Choices and Personal Responsibility51:37 Politics, Change, and the Path ForwardCheck out Dr. Urban Kiernan's Podcast: https://www.youtube.com/@DecodingHealthPodcastFollow Dr. Urban Kiernan on Instagram: https://www.instagram.com/light_bearer/Follow us on Instagram and Facebook!https://www.instagram.com/chronically_healthyllc/https://www.facebook.com/profile.php?id=100093317265924Overcome chronic illness and take back control of your health! For a FREE Consultation go to: https://chronicallyhealthyllc.xyz/
Embed this episode
What this episode covers
In this episode of the Diagnosis Redefined podcast, host Erica Anderson engages in a deep conversation with Dr. Urban Kiernan about the complexities of navigating health and wellness, particularly in the context of pharmaceuticals and therapeutics. They discuss the importance of personal responsibility in health decisions, the differences between traditional pharmaceuticals and newer therapeutic options, and the role of the FDA in drug approval. Dr. Kiernan shares his personal journey and ins...
NOW PLAYING
Ep. 33: Breaking the Pill Paradigm: A Biopharma Insider’s Take on Chronic Disease and the FDA
No transcript for this episode yet
Similar Episodes
No similar episodes found.